Revolution Medicines

Graphic of a line of blocks with percentages on them with one block in yellow showing an arrow increasing
Biotech

Small molecules are 'resurgent' in orphan drug R&D: Evaluate

Small molecules make up almost half of the 20 most valuable orphan drugs in development across biopharma, according to an Evaluate analysis.
James Waldron Mar 12, 2026 10:30am
Takeda

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics

Feb 9, 2026 8:00am
accelerated

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

Oct 17, 2025 8:30am
Parachute over a mountain in Switzerland

GSK chief steps down in stunning move—Chutes & Ladders

Oct 3, 2025 8:30am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Revolution taps Iambic's AI models in $25M discovery deal

Jul 9, 2025 11:19am
increase

Royalty signs off $2B to bankroll Revolution's RAS cancer drug

Jun 24, 2025 9:00am